• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

植入前基因筛查的下一步是什么?评估PGS的随机临床试验:必要但不充分。

What next for preimplantation genetic screening? Randomized clinical trial in assessing PGS: necessary but not sufficient.

作者信息

Simpson Joe Leigh

机构信息

College of Medicine, Florida International University, Building HLS II, Room 672, Miami, FL 33315, USA.

出版信息

Hum Reprod. 2008 Oct;23(10):2179-81. doi: 10.1093/humrep/den250. Epub 2008 Jul 9.

DOI:10.1093/humrep/den250
PMID:18614616
Abstract

The randomized clinical trial (RCT) is a powerful experimental design that when properly executed produces generalizable results. Conducting a RCT becomes complex when technical skills are required. Without requisite skills, a RCT may yield misleading results, an elegant RCT unwittingly generating spurious results due to technical inexperience. This pitfall is applicable to procedures used to evaluate assisted reproductive technologies. RCTs assessing the value of preimplantation genetic screening, also called preimplantation genetic diagnosis for aneuploidy testing--require three general prerequisites--proper study design, skilled operators (embryo biopsy), and skilled laboratory cytogeneticists (diagnosis). Lacking either of the latter two, even an elegantly designed RCT is not necessarily valid.

摘要

随机临床试验(RCT)是一种强大的实验设计,若执行得当,可产生具有广泛适用性的结果。当需要技术技能时,进行随机临床试验就会变得复杂。若缺乏必要技能,随机临床试验可能会产生误导性结果,一项精心设计的随机临床试验可能会因技术经验不足而无意中产生虚假结果。这一缺陷适用于评估辅助生殖技术的程序。评估植入前基因筛查价值的随机临床试验,也称为用于非整倍体检测的植入前基因诊断,需要三个一般前提条件——恰当的研究设计、熟练的操作人员(胚胎活检)和熟练的实验室细胞遗传学家(诊断)。缺少后两者中的任何一个,即使是设计精巧的随机临床试验也不一定有效。

相似文献

1
What next for preimplantation genetic screening? Randomized clinical trial in assessing PGS: necessary but not sufficient.植入前基因筛查的下一步是什么?评估PGS的随机临床试验:必要但不充分。
Hum Reprod. 2008 Oct;23(10):2179-81. doi: 10.1093/humrep/den250. Epub 2008 Jul 9.
2
What next for preimplantation genetic screening? Beyond aneuploidy.植入前基因筛查的下一步是什么?超越非整倍体。
Hum Reprod. 2009 Jul;24(7):1538-41. doi: 10.1093/humrep/dep078. Epub 2009 Apr 4.
3
What next for preimplantation genetic screening? More randomized controlled trials needed?胚胎植入前基因筛查的下一步是什么?需要更多随机对照试验吗?
Hum Reprod. 2008 Dec;23(12):2626-8. doi: 10.1093/humrep/den376. Epub 2008 Oct 23.
4
Substandard application of preimplantation genetic screening may interfere with its clinical success.胚胎植入前基因筛查应用不规范可能会影响其临床效果。
Fertil Steril. 2007 Oct;88(4):781-4. doi: 10.1016/j.fertnstert.2007.08.002.
5
What next for preimplantation genetic screening? A clinician's perspective.胚胎植入前基因筛查的下一步是什么?临床医生的观点。
Hum Reprod. 2008 Aug;23(8):1686-90. doi: 10.1093/humrep/den241. Epub 2008 Jun 24.
6
Comment 1 on Staessen et al. (2004). Design and analysis of a randomized controlled trial studying preimplantation genetic screening.
Hum Reprod. 2005 Aug;20(8):2362-3; author reply 2364-5. doi: 10.1093/humrep/deh879.
7
What next for preimplantation genetic screening (PGS)? A position statement from the ESHRE PGD Consortium Steering Committee.胚胎植入前遗传学筛查(PGS)的下一步是什么?ESHRE PGD 联盟指导委员会的立场声明。
Hum Reprod. 2010 Apr;25(4):821-3. doi: 10.1093/humrep/dep476. Epub 2010 Feb 2.
8
What next for preimplantation genetic screening?植入前基因筛查的下一步是什么?
Hum Reprod. 2008 Mar;23(3):478-80. doi: 10.1093/humrep/dem424. Epub 2008 Jan 17.
9
Preimplantation genetic screening does not improve delivery rate in women under the age of 36 following single-embryo transfer.胚胎植入前基因筛查并不能提高36岁以下女性单胚胎移植后的分娩率。
Hum Reprod. 2008 Dec;23(12):2818-25. doi: 10.1093/humrep/den367. Epub 2008 Oct 17.
10
What next for preimplantation genetic screening (PGS)? Experience with blastocyst biopsy and testing for aneuploidy.胚胎植入前遗传学筛查(PGS)的下一步是什么?囊胚活检和非整倍体检测的经验。
Hum Reprod. 2008 Jul;23(7):1476-8. doi: 10.1093/humrep/den129.

引用本文的文献

1
Fluorescent in situ hybridization of human sperm: diagnostics, indications, and therapeutic implications.人类精子的荧光原位杂交:诊断、适应证及治疗意义
Fertil Steril. 2014 Dec;102(6):1534-9. doi: 10.1016/j.fertnstert.2014.09.013. Epub 2014 Oct 22.
2
New tools for embryo selection: comprehensive chromosome screening by array comparative genomic hybridization.胚胎选择的新工具:通过阵列比较基因组杂交进行全面染色体筛查。
Biomed Res Int. 2014;2014:517125. doi: 10.1155/2014/517125. Epub 2014 Apr 29.
3
Pre-implantation genetic screening using fluorescence in situ hybridization in couples of Indian ethnicity: Is there a scope?
印度裔夫妇中使用荧光原位杂交技术进行植入前基因筛查:是否有应用空间?
J Hum Reprod Sci. 2014 Jan;7(1):25-9. doi: 10.4103/0974-1208.130812.
4
False positive rate of an arrayCGH platform for single-cell preimplantation genetic screening and subsequent clinical application on day-3.单细胞植入前遗传学筛查的 arrayCGH 平台的假阳性率及其后续在第 3 天的临床应用。
J Assist Reprod Genet. 2013 Jan;30(1):143-9. doi: 10.1007/s10815-012-9918-4. Epub 2012 Dec 20.
5
Are zona pellucida laser drilling and polar body biopsy safe for in vitro matured oocytes?卵透明带激光打孔和极体活检对体外成熟卵母细胞安全吗?
J Assist Reprod Genet. 2010 Jul;27(7):423-7. doi: 10.1007/s10815-010-9422-7. Epub 2010 May 22.
6
Quantitative decision-making in preimplantation genetic (aneuploidy) screening (PGS).胚胎植入前遗传学(非整倍体)筛查(PGS)中的定量决策。
J Assist Reprod Genet. 2009 Sep-Oct;26(9-10):487-502. doi: 10.1007/s10815-009-9352-4. Epub 2009 Oct 22.
7
What next for preimplantation genetic screening? High mitotic chromosome instability rate provides the biological basis for the low success rate.胚胎植入前遗传学筛查的下一步是什么?高有丝分裂染色体不稳定性率为低成功率提供了生物学基础。
Hum Reprod. 2009 Nov;24(11):2679-82. doi: 10.1093/humrep/dep266. Epub 2009 Jul 24.